Low glycaemic index diet in patients prescribed clozapine: Pilot study

Psychiatric Bulletin

Volumn 28, Issue 8, 2004, Pages 292-294

  Smith, Helen ^a   White, Tom ^a  

^a Murray Royal Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLESTEROL; CLOZAPINE; GLUCOSE; VALPROIC ACID;

ARTICLE; BODY WEIGHT; BODY WEIGHT DISORDER; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLYCEMIC INDEX; HUMAN; MENTAL PATIENT; PILOT STUDY; PRESCRIPTION; RISK REDUCTION; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT REDUCTION;

EID: 4344681980     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.28.8.292     Document Type: Article

References (6)

1. HENDENMALM, K., HAGG, S., MALIN, M., et al (2002) Glucose intolerance with atypical antipyhotics. Drug Safety, 25, 1107-1116.
2. KOLLER, E., SCHNEIDER, B., BENNETT, K., et al (2001) Clozapine-associated diabetes. American Journal of Medicine, 111, 716-723.
3. KUNAR, S. (2002) New dietary advice for diabetes from the American Diabetes Association. Nutrition Bulletin, 27, 93-96.
4. LINDENMAYER, J. P., CZOBOR, P., VOLAVKA, J., et al (2003) Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. American Journal of Psychiatry, 160, 290-296.
5. MIR, S. & TAYLOR, D. (2000) Atypical antipsychotics and hyperglycaemia. International Clinical Psychopharmacology, 16, 63-74.
6. PAWLAK, D. B., EBBELING, C. B. & LUDWIG, D. S. (2002) Should obese patients be counselled to follow a low-glycaemia index diet? Yes. Obesity Review, 3, 235-243.